Literature DB >> 11025910

Functional impairment and cognition in bipolar disorder.

C A Zarate1, M Tohen, M Land, S Cavanagh.   

Abstract

Bipolar disorder is a common, chronic and severe mental disorder, affecting approximately 2% of the adult population. Bipolar disorder causes substantial psychosocial morbidity that frequently affects the patient's marriage, children, occupation, and other aspects of the patient's life. Few studies have examined the functional impairment in patients with affective illness. Earlier outcome studies of mania reported favorable long-term outcomes. However, modern outcome studies have found that a majority of bipolar patients evidence high rates of functional impairment. These low reports of functional recovery rates are particularly surprising. The basis for such limited functional recovery is not entirely clear. Factors associated with functional dysfunction include presence of inter-episode symptoms, neuroleptic treatment, lower social economic class, and lower premorbid function. Cognitive dysfunction, a symptom domain of schizophrenia, has been identified as an important measure of outcome in the treatment of schizophrenia. Recently, there has been some suggestion that there may be impaired neuropsychological performance in euthymic patients with recurring mood disorders. Whether impaired neuropsychological performance in associated with the functional impairment in bipolar patients who have achieved syndromal recovery is an intriguing question. The literature on functional impairment and cognition in bipolar disorder is reviewed.

Entities:  

Mesh:

Year:  2000        PMID: 11025910     DOI: 10.1023/a:1004632206684

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  56 in total

1.  Bipolar affective disorder and alcoholism.

Authors:  J R Morrison
Journal:  Am J Psychiatry       Date:  1974-10       Impact factor: 18.112

2.  The course of manic-depressive psychosis. A follow up investigation of 215 patients.

Authors:  O Bratfos; J O Haug
Journal:  Acta Psychiatr Scand       Date:  1968       Impact factor: 6.392

3.  A history of substance abuse complicates remission from acute mania in bipolar disorder.

Authors:  J F Goldberg; J L Garno; A C Leon; J H Kocsis; L Portera
Journal:  J Clin Psychiatry       Date:  1999-11       Impact factor: 4.384

4.  Levels of functioning and well-being in recovered psychotic versus nonpsychotic mania.

Authors:  G M MacQueen; L T Young; J C Robb; R G Cooke; R T Joffe
Journal:  J Affect Disord       Date:  1997-10       Impact factor: 4.839

Review 5.  Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment.

Authors:  H Y Meltzer; P A Thompson; M A Lee; R Ranjan
Journal:  Neuropsychopharmacology       Date:  1996-03       Impact factor: 7.853

6.  Cognitive impairment in the euthymic phase of chronic unipolar depression.

Authors:  S Paradiso; G J Lamberty; M J Garvey; R G Robinson
Journal:  J Nerv Ment Dis       Date:  1997-12       Impact factor: 2.254

7.  Substance abuse and bipolar affective disorder.

Authors:  S C Sonne; K T Brady; W A Morton
Journal:  J Nerv Ment Dis       Date:  1994-06       Impact factor: 2.254

8.  Long-term outcome of major psychoses. I. Schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions.

Authors:  M T Tsuang; R F Woolson; J A Fleming
Journal:  Arch Gen Psychiatry       Date:  1979-11

9.  Outcome of bipolar disorder on long-term treatment with lithium.

Authors:  R A O'Connell; J A Mayo; L Flatow; B Cuthbertson; B E O'Brien
Journal:  Br J Psychiatry       Date:  1991-07       Impact factor: 9.319

10.  Symptoms and functioning of patients with bipolar disorder six months after hospitalization.

Authors:  G L Dion; M Tohen; W A Anthony; C S Waternaux
Journal:  Hosp Community Psychiatry       Date:  1988-06
View more
  33 in total

1.  Correlates of real world executive dysfunction in bipolar I disorder.

Authors:  Amy T Peters; Andrew D Peckham; Jonathan P Stange; Louisa G Sylvia; Natasha S Hansen; Stephanie Salcedo; Scott L Rauch; Andrew A Nierenberg; Darin D Dougherty; Thilo Deckersbach
Journal:  J Psychiatr Res       Date:  2014-03-02       Impact factor: 4.791

2.  Ecologically valid support for the link between cognitive and psychosocial functioning in bipolar disorder.

Authors:  Boaz Levy; Anna Marie Medina; Kathryn Hintz; Roger D Weiss
Journal:  Psychiatry Res       Date:  2010-07-31       Impact factor: 3.222

3.  Early life stress exacerbates cognitive dysfunction induced by d-amphetamine: amelioration by valproic acid.

Authors:  Rose Mary Carvalho Pinheiro; Maria Noêmia Martins de Lima; Gabriel Rodrigo Fries; Vanessa Athaíde Garcia; Juliana Presti-Torres; Luis Henrique Hallmenschlager; Luisa Azambuja Alcalde; Rafael Roesler; Monica Levy Andersen; João Quevedo; Flávio Kapczinski; Nadja Schröder
Journal:  J Neural Transm (Vienna)       Date:  2012-01-05       Impact factor: 3.575

Review 4.  Treatment of Functional Impairment in Patients with Bipolar Disorder.

Authors:  Jose Sanchez-Moreno; Anabel Martinez-Aran; Eduard Vieta
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

Review 5.  Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.

Authors:  Rosilla F Bachmann; Robert J Schloesser; Todd D Gould; Husseini K Manji
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

6.  Rumination and executive functions: Understanding cognitive vulnerability for psychopathology.

Authors:  Alta du Pont; Soo Hyun Rhee; Robin P Corley; John K Hewitt; Naomi P Friedman
Journal:  J Affect Disord       Date:  2019-06-22       Impact factor: 4.839

7.  Glucocorticoid receptor dysfunction: consequences for the pathophysiology and treatment of mood disorders.

Authors:  Aju Abraham; Stuart Watson; Allan H Young
Journal:  Indian J Psychiatry       Date:  2003-04       Impact factor: 1.759

8.  Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder.

Authors:  Angelo B Cunha; Ana C Andreazza; Fabiano A Gomes; Benicio N Frey; Leonardo E da Silveira; Carlos A Gonçalves; Flávio Kapczinski
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-02-23       Impact factor: 5.270

Review 9.  Epigenetic mechanisms in mood disorders: targeting neuroplasticity.

Authors:  D M Fass; F A Schroeder; R H Perlis; S J Haggarty
Journal:  Neuroscience       Date:  2013-01-30       Impact factor: 3.590

10.  Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder.

Authors:  Joel Jakobsson; Henrik Zetterberg; Kaj Blennow; Carl Johan Ekman; Anette G M Johansson; Mikael Landén
Journal:  Neuropsychopharmacology       Date:  2012-11-06       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.